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Editorial Comment 
Silent Myocardial Ischemia: 
Practical Application of 
Evolving Concepts* 
EZRA A. AMSTERDAM, MD, FACC 
Davis, CaliJornia 
initial report of Stern and Tzivoni (1 I), suggesting the 
prognostic importance of silent &hernia in patients with 
stable angina, has been extended by several studies indicat- 
ing that silent ischemia detected in this group by exercise 
stress (13) or ambulatory monitoring (13.14) is associated 
with extensive coronary artery disease (12,13) and an in- 
creased rate of coronary events (14). 
Recent investigations have considerably increased our un- 
derstanding of the challenging problem of silent myocardial 
ischemia. Its documentation and prevalence have been dem- 
onstrated and its prognostic significance in certain groups of 
patients with coronary artery disease has been recognized. It 
has been shown that silent ischemia is common throughout 
the entire spectrum of coronary artery disease, including 
stable angina (I), unstable angina (2), myocardial infarction 
(3) and occult coronary disease in apparently healthy. 
asymptomatic individuals (4). In addition to electrocardio- 
graphic (ECG) evidence of silent ischemia during exercise 
testing (5) and ambulatory monitoring (6), objective evidence 
of this phenomenon in patients with coronary disease has 
been provided by transient myocardial perfusion defects (7) 
and left ventricular wall motion abnormalities (8) unassoci- 
ated with symptoms. 
Prognostic significance of silent ischemia. Appreciation of 
the prognostic implications of silent myocardial ischemia has 
provided a rationale for its application in the management of 
certain subgroups of patients with coronary artery disease. 
Silent ischemia is recognized as a risk factor for coronary 
disease in totally asymptomatic persons (4) and this recog- 
nition has helped guide the individualized approach to pa- 
tients in this group (9). The impact of silent ischemia on 
prognosis has been most clearly documented by postinfarc- 
tion exercise testing in patients with recent myocardial 
infarction. Such testing has shown that impaired survival is 
related to ischemia irrespective of the presence or absence of 
associated symptoms (IO). These findings are now widely 
applied to risk stratification and management of patients 
after myocardial infarction. Subsequent studies (2) have 
implicated silent ischemia as a risk factor for future coronary 
events in patients with unstable angina. Most recently, the 
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The present study. In this issue of the Journal, Mulcahy 
and colleagues (15) address aspects of silent ischemia that 
are less well defined and have stimulated controversy: 1) the 
relation between treadmill exercise testing and ambulatory 
ECG monitoring in the detection of ischemia: and 2) the 
mechanisms of symptomatic versus asymptomatic ischemia. 
In their carefully performed study of 277 patients with 
documented coronary disease, Mulcahy et al. found that 
>90% of ischemic episodes detected by ambulatory ECG 
monitoring occurred in patients with a positive exercist test, 
which was also strongly correlated with both the frequency 
and the duration of ischemic episodes on ambulatory ECG 
monitoring that were silent or symptomatic in patients who 
were and were not receiving antianginal therapy. On the 
basis of these results, the authors conclude that “there is 
little indication to perform ambulatory ST segment monitor- 
ing in patients with a negative exercise test, except in 
patients who have a history suggestive of coronary artery 
spasm.” The authors agree with previous findings that 
ischemia during ambulatory ECG monitoring is associated 
with a lower heart rate than is ischemia with exercise (16). 
but they proffer alternatives to the frequently proposed 
hypothesis of coronary flow reduction (16) as the basis for 
silent ischemia. 
Role of exercise testing versus ambulatory ECG monitor- 
ing. Mulcahy et al. (15) extend data from previous studies 
indicating that the great majority of patients with &hernia 
detected during ambulatory ECG monitoring can be identi- 
fied by ischemia on exercise testing (6,16-18). These studies 
also show that. except in patients with coronary spasm. 
ischemia on ambulatory monitoring is distinctly unusual 
when exercise does not induce ischemia or when ischemia is 
present only on maximal exertion. Indeed. < 10% of patients 
with ischemia would have been missed by Mulcahy’s group 
if only exercise testing had been utilized, and an even 
smaller proportion would have been missed had those with 
coronary spasm been excluded. The study of Mulcahy et al. 
is the largest to compare exercise testing and ambulatory 
monitoring and they have demonstrated the applicability of 
their findings in terms of multiple clinical variables. The 
strong correlation between ischemia during exercise testing 
and that during daily activities supports their view that 
increased coronary vasomotor tone may be overemphasized 
as a singular mechanism for ischemia during the latter 
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circumstances, despite consistent demonstration of a lower 
heart rate during ischemia detected by ambulatory monitor- 
ing compared with exercise. Alternative explanations in- 
clude an increase in other hemodynamic variables that could 
augment myocardial oxygen demand (19) and methodologic 
factors such as failure to detect the precise heart rate at the 
onset of ischemia during exercise stress. However, it is 
noteworthy that the heart rate-pressure product is lower 
during nonexertional stress-induced ischemia than during 
exercise (20) and positron emission tomographic findings are 
consistent with reduction of myocardial perfusion during 
nonexertional ischemia (21). Further elucidation of the 
mechanisms of ischemia during daily activity and the signif- 
icance of the heart rate differential in relation to exercise- 
induced ischemia must await sophisticated studies with the 
capacity to monitor multiple determinants of myocardial 
oxygen demand and to assess coronary flow in larger num- 
bers of patients. 
Conclusions. Although in most instances ambulatory 
ECG monitoring adds little to the data obtained from exer- 
cise testing in the detection of ischemia, it may provide 
important additional information. Thus, in patients with 
stable coronary artery disease and a positive exercise test, 
prolonged cumulative ischemia on ambulatory monitoring 
has recently identified extensive coronary disease (13) and 
an adverse prognosis (14). In addition, the value of ambula- 
tory ECG monitoring is established in determining the rela- 
tion of ischemia to specific activities, the frequency and total 
duration of ischemia, the effect of therapy on total ischemic 
activity and the probability of coronary artery spasm. Al- 
though further investigation is needed to clarify the indica- 
tions for several of the many applications of ambulatory 
ECG monitoring in assessing ischemia, current studies are 
providing a rational basis for its more optimal utilization in 
patients with coronary artery disease. 
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